Skin and gastrointestinal tumors in dogs

Pre-Screen here buttonPDF iconEmail icon


Collie dog standing Optical coherence imaging (OCT) is a type of optical imaging that can evaluate tissues with microscopic detail without damaging them. The purpose of this study is to determine the diagnostic accuracy of the use of polarization-sensitive optical coherence tomography (PS-OCT) to detect residual tumor following resection of gastrointestinal, skin or subcutaneous tumors in dogs. This clinical investigation will be the first evaluation of PS-OCT imaging in a clinically relevant and heterogenous population of dogs with gastrointestinal, skin and subcutaneous tumors. This investigation aims to improve the accuracy of the surgical margin assessment in companion animals and improve the accuracy of surgical treatment of canine cancer.

What qualifies my pet for this trial?

To participate in this clinical trial your dog must:

  • Cytology or histopathology confirmation of relevant tumor type (except lipoma)
  • Dog undergoing surgical excision of relevant tumor type at OSU

What does enrolling in this clinical trial involve?

Dogs will undergo surgery to remove their tumor, following removal the tumor will be scanned with polarization sensitive optical coherence tomography to assess the surgical margins for residual cancer cells. The specimen will then undergo thorough histopathological assessment.

Client Compensation

Pet owners are financially responsible for all costs associated with evaluation and surgery. Each pet owner receiving surgery at OSU will receive $70 credit to their account to help with the costs of the histopathology evaluation.


Dr. Laura Selmic

If you believe your pet may be eligible to enter this study,
please fill out a pre-screening questionnaire.

      Pre-Screen here button